Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTempleton Emerging Markets Regulatory News (TEM)

Share Price Information for Templeton Emerging Markets (TEM)

Share Price is delayed by 15 minutes
Get Live Data
314.00    -7.00 (-2.18%)
Bid:
313.50
Ask:
314.00
Spread: 0.50 (0.159%)
Market Cap: £2.74b
TEM Live PriceLast checked at - London Stock Exchange

Intraday Templeton Emerging Markets Share Chart

Debt Facility

31 Jan 2025 15:26

RNS Number : 5192V
Templeton Emerging Markets IT PLC
31 January 2025
 

Templeton Emerging Markets Investment Trust PLC (the "Company")

Legal Entity Identifier: 5493002NMTB70RZBXO96

31 January 2025

 

Debt Facility

The Company's existing £100 million fixed rate loan matures on 31 January 2025. The Company has entered into a £122 million multi-currency revolving loan facility with The Bank of Nova Scotia, London branch. The loan facility will be available for 364 days, from 31 January 2025 to 30 January 2026.

 

Drawings under the £122 million revolving loan facility may be in sterling, US dollars and offshore renminbi (Chinese Yuan, CNH). There is a margin of 1.1% per annum over the relevant market reference rate on drawings in any of the three currencies allowed under the facility (GBP, USD or CNH) and a commitment fee of 0.40% per annum on undrawn amounts. The Company will draw down £80 million equivalent in pounds sterling today, 31 January 2025. The proceeds, along with £20m cash, will be applied to repay the fixed rate loan today.

 

The Company has no other debt.

 

 

For further information please email temitcosec@franklintempleton.com

 

 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area, Canada, Australia, Japan or the Republic of South Africa.

 

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPKDBBPBKDNDN
Date   Source Headline
23rd Jun 20254:54 pmRNSTransaction in Own Shares
23rd Jun 20259:02 amRNSNet Asset Value(s)
20th Jun 20254:56 pmRNSTransaction in Own Shares
20th Jun 20259:39 amRNSNet Asset Value(s)
20th Jun 20258:05 amRNSPortfolio Update
19th Jun 20254:56 pmRNSTransaction in Own Shares
19th Jun 20259:00 amRNSNet Asset Value(s)
18th Jun 20254:56 pmRNSTransaction in Own Shares
18th Jun 20259:29 amRNSNet Asset Value(s)
17th Jun 20255:00 pmRNSTransaction in Own Shares
17th Jun 20258:31 amRNSNet Asset Value(s)
16th Jun 20254:55 pmRNSTransaction in Own Shares
16th Jun 20259:16 amRNSNet Asset Value(s)
13th Jun 20255:00 pmRNSTransaction in Own Shares
13th Jun 202511:31 amRNSNZ Climate Related Disclosures Exemption Notice
13th Jun 20258:09 amRNSNet Asset Value(s)
12th Jun 20254:57 pmRNSTransaction in Own Shares
12th Jun 20259:25 amRNSNet Asset Value(s)
11th Jun 20254:56 pmRNSTransaction in Own Shares
11th Jun 20259:34 amRNSNet Asset Value(s)
10th Jun 20254:51 pmRNSTransaction in Own Shares
10th Jun 20258:07 amRNSNet Asset Value(s)
9th Jun 20254:54 pmRNSTransaction in Own Shares
9th Jun 20258:50 amRNSNet Asset Value(s)
6th Jun 20255:01 pmRNSTransaction in Own Shares
6th Jun 20253:40 pmRNSDividend Declaration
6th Jun 20253:36 pmRNSStatement of Annual Results to 31 March 2025
6th Jun 20259:12 amRNSNet Asset Value(s)
5th Jun 20254:54 pmRNSTransaction in Own Shares
5th Jun 20258:54 amRNSNet Asset Value(s)
4th Jun 20254:56 pmRNSTransaction in Own Shares
4th Jun 20258:40 amRNSNet Asset Value(s)
4th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Jun 20255:01 pmRNSTransaction in Own Shares
3rd Jun 20258:27 amRNSNet Asset Value(s)
2nd Jun 20254:57 pmRNSTransaction in Own Shares
2nd Jun 202510:04 amRNSTotal Voting Rights
2nd Jun 20259:05 amRNSNet Asset Value(s)
30th May 20255:00 pmRNSTransaction in Own Shares
30th May 20258:45 amRNSNet Asset Value(s)
29th May 20254:54 pmRNSTransaction in Own Shares
29th May 20258:42 amRNSNet Asset Value(s)
28th May 20254:58 pmRNSTransaction in Own Shares
28th May 20258:19 amRNSNet Asset Value(s)
27th May 20254:56 pmRNSTransaction in Own Shares
27th May 202510:13 amRNSNet Asset Value(s)
23rd May 20255:00 pmRNSTransaction in Own Shares
23rd May 20258:50 amRNSNet Asset Value(s)
22nd May 20259:50 amRNSNet Asset Value(s)
21st May 20258:22 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.